Last updated: August 17, 2026

Former F1 driver Michael Schumacher is reportedly to undergo stem cell therapy.

 

Seven-time Formula One world champion Michael Schumacher is being treated with a cutting-edge stem-cell therapy in a Paris hospital, according to reports in France.

A report in Le Parisien claims that Schumacher was admitted under tight guard on Monday to the Georges-Pompidou hospital.

The paper says the treatment is scheduled to be administered on Tuesday.

The Paris hospitals authority, citing France’s strict medical privacy rules, said it could not comment on the claims.

 

His long-time manager Sabine Kehm has yet to comment.

Schumacher, 50, suffered a near-fatal brain injury in a 2013 skiing accident in the French Alps.

Schumacher’s condition stabilised after he was placed in a drug-induced coma, from which he later emerged.

Since September 2014, he has been cared for at home on the shores of Lake Geneva.

In a radio interview in July, his former Ferrari boss Jean Todt said they had been watching Formula One together on television.

He added: “Michael is in the best hands and is well looked after in his house. He does not give up and keeps fighting.”

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.


NBScience

contract research organization

WhatsApp